AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,806.00p
   
  • Change Today:
      26.00p
  • 52 Week High: 12,972.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.70m
  • Volume: 2,924,907
  • Market Cap: £198,583m
  • RiskGrade: 123

Latest ShareCast News

AstraZeneca's Baxdrostat hits Phase III endpoint in resistant hypertension

By Iain Gilbert

Date: Tuesday 07 Oct 2025

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that Baxdrostat had met its primary endpoint in the Bax24 Phase III trial, delivering a "statistically significant and clinically meaningful reduction" in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension.

AstraZeneca ShareCast News

London midday: Stocks mixed with French and US f... 06-Oct-2025 ShareCast
London midday: UK stocks keep grinding towards y... 03-Oct-2025 ShareCast
Trump's MFN deal with Pfizer could be bellwether... 01-Oct-2025 ShareCast
AstraZeneca to list in New York, retain London l... 29-Sep-2025 ShareCast
Trump to impose tariffs of 100% on branded drug ... 26-Sep-2025 ShareCast

AstraZeneca Regulatory News

Baxdrostat met primary endpoint in Bax24 Ph3 trial 07-Oct-2025 07:00 RNS
Datroway improved OS and PFS in TROPION-Breast02 06-Oct-2025 07:30 RNS
Total Voting Rights 01-Oct-2025 15:00 RNS
Enhertu improved IDFS in early BC in DB-05 29-Sep-2025 07:30 RNS
AZN harmonises listing structure 29-Sep-2025 07:00 RNS

AstraZeneca Newspaper Links

AstraZeneca plans direct US listing in blow to L... 29-Sep-2025 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,806.00p
Change Today 26.00p
% Change 0.20 %
52 Week High 12,972.00
52 Week Low 9,667.00
Volume 2,924,907
Shares Issued 1,550.70m
Market Cap £198,583m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 08-Oct-2025

Time Volume / Share Price
16:36 130,986 @ 12,806.00p
16:21 0 @ 12,818.00p
16:05 0 @ 12,808.00p
14:51 266,980 @ 12,806.00p
14:51 266,980 @ 12,806.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page